Announced
Completed
Financials
Sources
Tags
Private Equity
Minority
China
pharmaceutical
Venture Capital
Domestic
Pharmaceuticals
Friendly
Completed
Private
Acquisition
Synopsis
A consortium of investors led a $270m funding round in Yaoshibang, a Chinese pharmaceutical trading platform. The consortium consisted of Zhejiang Pearl River Investment Management, Baidu, Green Pine Capital Partners and Guangzhou City Construction Investment. Following the investment, Yaoshibang will look to upgrade digital sales, marketing systems, and its data-sharing platform.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.